loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 210557 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 PALATIN TECHNOLOGIES (1)

filter

01 SOLUTION;SUBCUTANEOUS (1)

filter

01 RX (1)

filter

01 VYLEESI (AUTOINJECTOR) (1)

filter

01 Yes (1)

URL Supplier Web Content
SOLUTION; SUBCUTAN...
EQ 1.75MG BASE/0.3...
2019-06-21
210557
VYLEESI (AUTOINJEC...
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 210557

Looking for FDA Orange Book APPLICATION 210557 1

19

Palatin Technologies, based in U.S.A, is a pharmaceutical company.

One of their notable products is BREMELANOTIDE ACETATE, with a corresponding application number 210557.

Regulatory Information RX

With a dosage strength EQ 1.75MG BASE/0.3ML (EQ 1.75MG BASE/0.3 ML)

Dosage Form Route SOLUTION; SUBCUTANEOUS

Reference Listed Drug Yes

Approved since 2019-06-21

Post Enquiry
POST ENQUIRY